Meeder Asset Management Inc. Takes $77,000 Position in Addus HomeCare Co. (NASDAQ:ADUS)

Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 611 shares of the company’s stock, valued at approximately $77,000.

A number of other hedge funds also recently added to or reduced their stakes in ADUS. Charles Schwab Investment Management Inc. raised its position in Addus HomeCare by 8.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 227,209 shares of the company’s stock valued at $30,226,000 after purchasing an additional 18,555 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Addus HomeCare by 17.8% during the third quarter. The Manufacturers Life Insurance Company now owns 9,625 shares of the company’s stock worth $1,280,000 after buying an additional 1,454 shares during the period. FMR LLC raised its holdings in Addus HomeCare by 22.8% in the third quarter. FMR LLC now owns 86,464 shares of the company’s stock valued at $11,502,000 after acquiring an additional 16,040 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in Addus HomeCare by 26.3% in the third quarter. BNP Paribas Financial Markets now owns 32,067 shares of the company’s stock worth $4,266,000 after acquiring an additional 6,671 shares during the last quarter. Finally, Glenmede Trust Co. NA acquired a new position in Addus HomeCare during the 3rd quarter worth approximately $491,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Macquarie reaffirmed an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price on the stock. Finally, Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Price Performance

ADUS stock opened at $98.93 on Wednesday. The company has a market cap of $1.80 billion, a price-to-earnings ratio of 22.64, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. The company has a fifty day moving average price of $106.87 and a 200 day moving average price of $120.18. Addus HomeCare Co. has a 12 month low of $87.88 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. As a group, analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.